59 results about "Internal bleeding" patented technology

Methods and apparatus for the remote coagulation of blood using high-intensity focused ultrasound (HIFU) are provided. A remote hemostasis method comprises identifying a site of internal bleeding and focusing therapeutic ultrasound energy on the site, the energy being focused through an intervening tissue. An apparatus for producing remote hemostasis comprises a focused therapeutic ultrasound radiating surface and a sensor for identifying a site of internal bleeding, with a registration means coupled to the radiating surface and the sensor to bring a focal target and the bleeding site into alignment. The sensor generally comprises a Doppler imaging display. Hemostasis enhancing agents may be introduced to the site for actuation by the ultrasound energy.

An endoscope or other medical device includes an elongated shaft having a flexible proximal section, an articulatable distal region, and distal tip. The endoscope or other device includes an associated hemostasis device for treating internal bleeding during a contemporaneous medial procedure. Embodiments of the present invention may incorporate mechanical, chemical, and/or electrical techniques for performing hemostasis.

A simulator (1) has a body form apparatus (2) with a skin-like panel (4) through which laproscopic instruments (5) are inserted. Cameras (10) capture video images of internal movement of the instruments (5) and a computer (6) processes them. 3D positional data is generated using stereo triangulation and is linked with the associated video images. A graphics engine (60) uses the 3D data to generate graphical representations of internal scenes. A blending function (70) blends real and recorded images, or real and simulated images to allow demonstration of effects such as internal bleeding or suturing.

A detachable electrode and anchor utilized with electrode leads and leadless medical implants that enable explantation of the electrode while leaving the anchor in place. The detachable electrode and anchor utilizes a detachable mechanism that detachably couples the electrode to the anchor. Embodiments do not require removal of existing scar tissue before explantation, which minimize chances of internal bleeding at the extraction site. Embodiments also minimize impact on the vein in which the electrode lead travels by eliminating use of a necessarily larger diameter sheath that is utilized around the electrode lead to remove the electrode lead and attached anchor.

A method and apparatus for the endoscopic application of self-closing medical clips (3), in particular, for arresting internal bleeding. The distal end of a catheter tube (1) is introduced into the body of a living being to be treated. Several clips (3), arranged successively in the catheter tube (1), are pushed forward in the direction of the tube distal end by a user device located at the proximal end of the catheter tube (1). The foremost clip (3) to be applied is pushed out of the distal end and opened by an actuation device. The actuation device includes an actuation element (21) which can be actuated by the user device, moved longitudinally into the catheter tube (1), and acts on the first front clip (3), as well as a control part (25) which converts the actuation force of the actuation element into an opening movement of the legs (5) of the clip (3). After the opening of the clip (3), the actuation element (21) is separated from the clip (3), for releasing the clip to close its legs (5) for application, and to functionally link with the following clip (3) in the catheter tube (1).

Intubation is a potentially dangerous invasive procedure with many plausible errors, such as over-inflation of a cuff and insertion of an intubation tube in the wrong lumen, potentially resulting in a patient's internal bleeding, suffocation, or even death. An intubation aide according to example embodiments of the present invention allows intubation of a patient, while eliminating potential injury to the patient, increasing accuracy and reliability of the placement of the intubation tube, and drastically decreasing procedural time. Within moments of insertion of the device into a patient, the medical caregiver knows, with complete certainty, the location of the intubation device without applying traditional time-consuming tasks. Embodiments also provide patient safety, if intubated for a prolonged periods, by regulating an inflation pressure of the cuff. The intubation aide can also be used for training purposes and is ideal for intubation in hospital and field settings.

Abstract: An EIT system (1) adapted to detect internal bleeding in a body portion, the EIT system (1) comprising a plurality of electrodes (3) adapted in use to extend in a substantially linear orientation across one side only of the body portion and to be applied in electrical contact with the skin of the body portion, a current source adapted to cyclically apply an electric current between one pair of the electrodes (3), a voltage measuring means to measure the voltage across each of the other pairs of the electrodes resulting from the current, a data collection system (2) and a data analysis system (4) to analyse data resulting from the voltages that are measured by the voltage measuring means, wherein the analysis system (4) is configured to obtain quantitative information related to amounts and rates of conductive tissue changes occurring in the body, based on an EIT analysis equivalent to that obtained from data derived from electrodes spaced around the full perimeter of the body portion. Also disclosed is an electrode belt suitable for bioelectrical use and in particular for detection of change of volume of tissue in a body portion.

Apparatus and methods for capsule endoscopy are described for locating, positioning, steering, aiming and tracking of an endoscopy capsule (100) within a patient's esophagus and stomach. The apparatus includes an endoscopy capsule (100) with a magnetic element (110), an external capsule positioning system (200) including at least one magnet (202) movable along a track (204) for positioning the endoscopy capsule (100) within a patient. Also described are apparatus and methods for performing endoscopic spectroscopy using different wavelengths of light and other imaging technologies to diagnose various disease conditions, such as premalignant or inflammatory changes and internal bleeding.

Passive physiological monitoring apparatus has a sensor for sensing physiological phenomenon and method converter converts sensed data into electrical signals and a computer receives and computes the signals and output computed data for real-time interactive display. The sensor is a piezoelectric film of polyvinylidene fluoride. Signals detected include mechanical, thermal and acoustic signatures reflecting cardiac output, cardiac function, internal bleeding, respiratory, pulse, apnea and temperature. The sensor may be an array provided in a MEDEVAC litter or other device for measuring acoustic and hydraulic signals from the body of a patient for field monitoring, hospital monitoring, transport monitoring, home, remote monitoring.

Surgical methods of and kits for applying and stabilizing a mass of fibrin sealant or platelet concentrate at the site of surgical attachment of an implantable medical device to effect hemostasis to stem internal bleeding at the site of surgical attachment are disclosed. A mass of fibrin sealant or platelet concentrate is applied onto a porous fabric, whereby the mass is supported in the interstices or pores of the fabric, and the supported mass is applied against the site of high pressure blood leakage. The supported mass achieves hemostasis as it does not wash away from the site. The present invention is particularly useful to effect hemostasis at sutures and suture holes extending through thin-walled tissue valves and grafts when such tissue valves or grafts are sutured in place, particularly at high blood pressure sites as at the valve annulus of the aortic valve or the aorta.

An ultrasound based technique for detecting and imaging vibrations in tissue caused by eddies produced during bleeding through punctured arteries or from organs. A clutter signal, normally suppressed in conventional color flow imaging, is employed to detect and characterize local tissue vibrations, to detect internal bleeding in an image, or as an audible or palpable signal, or a readout. Using a tissue vibration image, the origin and extent of vibrations relative to the underlying anatomy and blood flow can be visualized in real time, enabling measurements of vibration amplitude, frequency, and spatial distribution. Bleeding rate can be determined from the frequency and amplitude of the vibrations. Signal processing algorithms usable to identify tissue vibrations from an ensemble of 2D ultrasound data include those based on phase decomposition, spectral estimation using eigendecomposition, and spectral estimation using autoregressive modeling for isolating vibrations from clutter, blood flow, and noise.

The invention discloses a new Chinese herbal composite for epistaxis treatment and a preparation method thereof. The Chinese herbal composite of the invention is mainly prepared by the following ingredients of cacumen platycladi, Japanese thistle herb, herba cirsii, charred radix sanguisorbae, rhizoma imperatae, ramie root, radix notoginseng, radix rubiae, charred pollen typhae, charred folium artemisiae argyi, ophicalcitum, rosewood heart wood, crinis carbonisatus, bletilla, hairyvein agrimonia herb, catechu, plant soot, crinis trachycarpi, catechu, dried rehmannia root, radix trichosanthis and the like. The Chinese herbal composite of the invention can be prepared into any common oral preparation and external powder according to conventional Chinese medicine preparation method. The composite can obviously improve nasal cavity bleeding, oronasal bleeding and seven apertures bleeding, and also promote internal bleeding and other symptoms, which has reliable and apparent clinical effect and fast desired effect. The Chinese herbal composite of the invention also has the advantages of low cost and basically no toxic or side effect and the like.

Exemplary apparatus and process can be provided for determining at least one characteristic of an anatomical structure. For example, it is possible to generate an acoustic wave in the anatomical structure using an opto-accoustic arrangement It is then possible to detect the acoustic wave and determine whether at least one blood pool is present at or in the anatomical structure as a function of at least one property of the acoustic wave. Further, it is possible to forward at least one first electro-magnetic radiation to at least one tissue of the anatomical structure, detect at least one second electro-magnetic radiation provided from the at least one tissue based on a motion of or within the at least one tissue to generate detection data, and determine the at least one characteristic of the at least one portion based on the detection data.

A method is provided for localizing an internal bleeding site whereby a protein or other factor involved in the clotting process is complexed to an imaging agent and injected into a patient believed to be at risk of internal bleeding. A clot in the patient will naturally accumulate a certain concentration of the injected complex, and within a short period of time the concentration becomes sufficient to be detected by an imaging apparatus. The imaging contrast agent may, for example, be an MRI contrast agent, a CT contrast agent, a PET agent, or a fluorescent substance.

Hepatic cirrhosis is considered a severe health problem in Mexico, since it is the third mortality cause in working-age people and there is no 100% effective treatment. Cirrhosis is characterized by an exacerbated increase of collagen in liver parenchyma, replacing the hepatocytes and thus provoking liver failure. This is one of the reasons why we have used a gene therapy through specific delivery to cirrhotic livers of the gene of human urokinase plasminogen activator (huPA), which activates mechanisms that induce the degradation of excess cellular matrix and stimulate hepatocyte proliferation, obtaining thus a fast re-establishment of the liver function. In the instant invention, the modified human uPA gene was inserted in the adenoviral vector (pAd-DeltahuPA), because it is not secreted and does not provoke hypercoagulation or spontaneous internal bleedings. Moreover, data from the bio-distribution essay with an adenoviral vector with reporter gene beta-gal have shown liver specificity as the target organ of the vector. Using ELISA, huPa protein was detected in liver homogenates (4500 pg/ml) in animals treated with pAd-DeltahuPA and was also intracellularly detected through immunochemistry in liver cuts (80% positive cells). huPa induced a dramatic fibrosis reduction (85%) on day 10 of vector administration, compared to control cirrhotic rats and 55% hepatocyte proliferation increase. Liver function tests (ALT, AST, alkaline phosphatase and bilirubin) dropped to nearly normal levels and hepatocyte proliferation was observed. Because of the two beneficial event cascades, gene therapy with modified huPA can be developed as a definite potential treatment for patients with liver cirrhosis.

The invention belongs to the field of biomedical materials, relates to a preparation method and application of a bacteriophagic hemostatic agent. The bacteriophagic hemostatic agent exhibits an RGD polypeptide by a bacteriophage exhibiting technology; the amino acid sequence of the polypeptide adopts a general formula as follows: Arg-Gly-Asp or other variants including three amino acids, namely Arg, Gly and Asp; the polypeptides is exhibited on the pVIII coat protein of bacteriophages. The bacteriophagic hemostatic agent has the following outstanding characteristics: (1) promotion of platelet activation: negatively charged platelets and fibrin in blood can be attracted, platelet adhesion can be increased and thrombosis can be promoted; (2) rapid hemostasis: through adhesion of a fibrin network in the blood to RGD bacteriophages, self-assembly and formation of a blood coagulating network can be accelerated, the hemostatic speed can be increased, the hemostatic effect can be promoted and the hemostatic mechanism can be improved; (3) wide application range: the bacteriophagic hemostatic agent is applicable to hemostasis of systemic blood loss, and especially provides a novel therapeutic method for treatment of internal bleeding of an organ.

The present invention relates to inhibitors of antithrombin III and the medical use thereof in treating or preventing bleeding. The inhibitors are preferably used in subjects suffering from an acquired or genetic bleeding disorder, such as haemophilia, or in a subjects having a clinical condition characterised by excessive bleeding, such as surgery, trauma and internal bleeding. The inhibitor of antithrombin III can e.g. a peptide, an aptamer or an antibody or antibody fragment that specifically binds to and inhibits antithrombin III.